[{"id":"3ec445cf-798e-4ad2-a912-f09ad90f4afa","acronym":"KEYNOTE 721","url":"https://clinicaltrials.gov/study/NCT03310957","created_at":"2021-01-18T16:21:08.891Z","updated_at":"2024-07-02T16:35:19.546Z","phase":"Phase 1/2","brief_title":"Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer","source_id_and_acronym":"NCT03310957 - KEYNOTE 721","lead_sponsor":"Seagen Inc.","biomarkers":" HER-2 • PD-L1","pipe":" | ","alterations":" HER-2 expression • PGR expression","tags":["HER-2 • PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression • PGR expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • ladiratuzumab vedotin (SGN-LIV1A)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 186","initiation":"Initiation: 02/27/2018","start_date":" 02/27/2018","primary_txt":" Primary completion: 03/31/2024","primary_completion_date":" 03/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-02-13"},{"id":"96856886-3ea5-45f0-884d-423acfcaaa86","acronym":"SGNLVA-001","url":"https://clinicaltrials.gov/study/NCT01969643","created_at":"2021-01-18T08:57:30.564Z","updated_at":"2024-07-02T16:35:53.859Z","phase":"Phase 1","brief_title":"A Safety Study of SGN-LIV1A in Breast Cancer Patients","source_id_and_acronym":"NCT01969643 - SGNLVA-001","lead_sponsor":"Seagen Inc.","biomarkers":" HER-2 • PD-L1 • ER • PGR","pipe":" | ","alterations":" PD-L1 expression • HER-2 positive • ER positive • HER-2 negative","tags":["HER-2 • PD-L1 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • HER-2 positive • ER positive • HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Herceptin (trastuzumab) • ladiratuzumab vedotin (SGN-LIV1A)"],"overall_status":"Completed","enrollment":" Enrollment 290","initiation":"Initiation: 10/22/2013","start_date":" 10/22/2013","primary_txt":" Primary completion: 02/04/2023","primary_completion_date":" 02/04/2023","study_txt":" Completion: 02/04/2023","study_completion_date":" 02/04/2023","last_update_posted":"2023-03-07"}]